Release Date: December 28, 2017
Expiration Date: December 28, 2018
Media: Internet - based
This infograph-ed™ program provides a visually engaging and interactive review of immune abnormalities and skin-barrier dysfunction in the development of atopic dermatitis (AD) and uses this understanding to facilitate treatment selection. Guidelines for diagnosis and management of AD will be presented, followed by a summary of current and emerging topical and systemic therapies that can help optimize treatment outcomes. This activity provides the practical skills necessary to educate patients in self-care, thereby reducing relapses and enhancing their health-related quality of life.
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Instructions for This Activity and Receiving Credit
The educational design of this activity addresses the needs of dermatologists, primary care physicians, nurse practitioners, physician assistants, and all other healthcare professionals involved in the care and treatment of patients with atopic dermatitis (AD).
Upon completion of this activity, you should be better prepared to:
Eric L. Simpson, MD, MCR
Director, Dermatology Clinical Trials
Department of Dermatology
Oregon Health & Science University
Disclosure: Grant/Research Support: GlaxoSmithKline, Roivant Sciences, Medimetriks, Eli Lilly, Vanda, Tioga; Consultant: Celgene, GlaxoSmithKline, Galderma, Menlo Therapeutics, Abbvie, Leo, Eli Lilly, Pfizer
The staff of PER® have no relevant financial relationships with commercial interests to disclose.
Physicians' Education Resource®, LLC (PER®)
The following contributors have no relevant financial relationships with commercial interests to disclose.
Planning Staff—David Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Jeannette Wick and Kathleen Bowen
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Instructions: To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.
Continuing education activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Multiple Myeloma
Feb 28, 2019
Feb 28, 2019
Feb 28, 2019
23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
February 28, 2019 - March 3, 2019